Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to determine the performance characteristics (sensitivity and specificity) of the Verinata Health Test to detect fetal Trisomy 21 (T21) compared to karyotype res...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Verinata Health, Inc.
NCT06925815 · Healthy Pregnant Women, Obese Pregnant Women, and more
NCT06976632 · Pregnant Women
NCT06523543 · Pregnant Women
NCT07467837 · Pregnant Women, Stretch Mark
NCT06357546 · Pregnant Women, Cesarean Section
Center for Fetal Medicine
Los Angeles, California
San Francisco Perinatal Associates
San Francisco, California
Women's Clinic of Northern Colorado
Fort Collins, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions